Arcturus Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Update and Pipeline Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. HOOD
7. DFTX
8. GOOGL
9. MU
10. IBM

Go back to Arcturus Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Update and Pipeline Progress

Arcturus Therapeutics (ARCT) Tops Q4 EPS by 25c

February 28, 2022 4:01 PM EST

Arcturus Therapeutics (NASDAQ: ARCT) reported Q4 EPS of ($1.47), $0.25 better than the analyst estimate of ($1.72). Revenue for the quarter came in at $5.8 million versus the consensus estimate of $14.72 million.

For earnings history and earnings-related data on Arcturus Therapeutics (ARCT) click here.

... More